Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)
Clinical trial NCT04257487 · RECRUITING
Trial details
- NCT number
- NCT04257487
- Sponsor
- Arianna Anticoagulazione Foundation
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-21
- Primary completion
- 2025-12-31
- Enrollment
- 1455
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.